Abstract
Using subtractive immunization to identify cell surface epitopes expressed in a metastasis-specific fashion on cells of the rat MT-W9 mammary carcinoma model, we generated a monoclonal antibody called M-N#1. This antibody binds specifically to metastasizing cells of the MT-W9 series and also to certain other metastasizing rat mammary carcinoma cell lines. We demonstrate that the M-N#1 antibody recognizes a fucosylated N-glycosyl sugar modification, and furthermore show that the epitope specificity of the M-N#1 antibody is for blood group antigen B subtypes 2, 3 and 4 with slight cross-reactivity with blood group antigen A subtype 2. The expression of these carbohydrate epitopes on MT-450 cells is functionally important, because the M-N#1 antibody efficiently inhibits MT-450 tumour growth in spontaneous metastasis assays. These results suggest that expression of the subtypes of blood group antigen B recognized by the M-N#1 antibody does not directly participate in the metastatic cascade but rather confers a growth or survival advantage on the tumour cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akahani S, Nangia-Makker P, Inohara H, Choi Kim H-R and Raz A. . 1997 Cancer Res. 57: 5272–5276.
Akiyama S, Yamada S and Yamada K. . 1989 J. Biol. Chem. 264: 18011–18018.
Brooks P, Lin J-M, French D and Quigley J. . 1993 J. Cell Biol. 122: 1351–1359.
Byrne G and Cox E. . 1986 Dev. Biol. 117: 442–455.
Chammas R, Veiga S, Line S, Potocnjak P and Brentani R. . 1991 J. Biol. Chem. 266: 3349–3355.
Chatterjee S and Kim U. . 1978 J. Natl. Cancer Inst. 61: 151–162.
Clausen H and Hakomori S. . 1989 Vox Sang 56: 1–20.
Dabelsteen E, Graem N, Clausen H and Hakomori S. . 1988 Cancer Res. 48: 181–187.
Dall P, Heider K-H, Sinn H-P, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P and Ponta H. . 1995 Int. J. Cancer 60: 471–477.
Denk H, Tappeiner G and Holzner J. . 1974 Eur. J. Cancer 10: 487–490.
Ghosh S, Roholt O and Kim U. . 1983 In Vitro 19: 919–928.
Goupille C, Hallouin F, Meflah K and LePendu J. . 1997 Glycobiology 7: 221–229.
Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Hauβmann I, Matzku S, Wenzel A, Ponta H and Herrlich P. . 1991 Cell 65: 13–24.
Hakomori S. . 1996 Cancer Res. 56: 5309–5318.
Hallouin F, Goupille C, LeCabellec M, Bara J and LePendu J. . 1998 Glycoconj. J. in press.
Harlow E and Lane D. . 1988 Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York.
Holmes E. . 1990 Carcinogenesis 11: 89–94.
Ichikawa T, Ichikawa I, Dong J, Hawkins A, Griffin C, Isaacs W, Oshimura M, Barrett J and Isaacs J. . 1992 Cancer Res. 52: 3486–3490.
Ichikawa T, Ichikawa I and Isaacs J. . 1991 Cancer Res. 51: 3788–3792.
Isaacs J, Heston W, Weissman R and Coffey D. . 1978 Cancer Res. 38: 4353–4359.
Isaacs J, Isaacs W, Feitz W and Scheres J. . 1986 Prostate 9: 261–281.
Kim U. . 1986 J. Surgical Oncol. 33: 151–165.
King M-J. . 1994 Biochim. Biophys. Acta 1197: 15–44.
Labarriere N, Piau JP, Otry C, Dennis M, Lustenberger P, Meflah K and Le Pendu J. . 1994 Cancer Res. 54: 6275–6281.
Le Marer N and Hughes R. . 1996 J. Cell Physiol. 168: 51–58.
Lee A, DeLellis R, Rosen P, Saigo P, Gangi M, Bagin R, Groshen S and Wolfe H. . 1985 Am. J. Clin. Pathol. 83: 308–319.
Lichtner RB and Nicolson GL. . 1987 Invasion Metastasis 7: 73–82.
Miyake M, Taki T, Hitomi S and Hakomori S. . 1992 New England J. Med. 327: 14–18.
Neri A, Ruoslahti E and Nicolson GL. . 1981 Cancer Res. 41: 5082–5095.
Ogawa J, Inoue H and Koide S. . 1996 Cancer Res. 56: 325–329.
Oriol R, Cooper J, Davies D and Keeling P. . 1984 Lab. Invest. 50: 514–518.
Raz A, Zhu D, Hogan V, Shah N, Raz T, Karkash R, Pazerini G and Carmi P. . 1990 Int. J. Cancer 46: 871–877.
Rudy W, Hofmann M, Schwartz-Albiez R, Zöller M, Heider K-H, Ponta H and Herrlich P. . 1993 Cancer Res. 53: 1262–1268.
Sato S and Hughes RC. . 1992 J. Biol. Chem. 267: 6983–6990.
Schoentag R, Primus F and Kuhns W. . 1987 Cancer Res. 47: 1695–1700.
Sleeman JP. . 1993 Oncogene 8: 1931–1941.
Sleeman J, Rudy W, Hofmann M, Moll J, Herrlich P and Ponta H. . 1996 J. Cell Biol. 135: 1139–1150.
Strauchen J, Bergman S and Hanson T. . 1980 Cancer 45: 2149–2155.
Sun J, Thurin J, Cooper H, Wang P, Mackiewicz M, Steplewski Z and Blaszczyk-Thurin M. . 1995 Proc. Natl. Acad. Sci. USA 92: 5724–5728.
Ura Y, Dion A, Williams C, Olsen B, Redfield E, Ishida M, Herlyn M and Major P. . 1992 Int. J. Cancer 50: 57–63.
Verma M. . 1994 Cancer Biochem. Biophys. 14: 151–162.
Vermeersch Williams C, Stechmann V and McLoon S. . 1992 Biotechniques 12: 842–847.
Vowden P, Lowe A, Lennox E and Bleehen N. . 1986 Br. J. Cancer 53: 313–319.
Wang J, Ambros R, Weber P and Rosano T. . 1995 Cancer Res. 55: 3654–3658.
Xing R and Rabbani S. . 1996 Int. J. Cancer 67: 423–429.
Yang R-Y, Hsu D and Liu F-T. . 1996 Proc. Natl. Acad. Sci. USA 93: 6737–6742.
Yoshimura M, Ihara Y, Matsuzawa Y and Taniguchi N. . 1996 J. Biol. Chem. 271: 13811–13815.
Yuan M, Itzkowitz H, Palekar A, Shamsuddin A, Phelps P, Trump B and Kim Y. . 1985 Cancer Res. 45: 4499–4511.
Zheng M, Fang H and Hakomori S. . 1994 J. Biol. Chem. 269: 12325–12331.
Acknowledgements
We thank Uschi Rahmsdorf and Anja Steffen for excellent technical assistance and Martin Hofmann for critically reading the manuscript. This work was supported by the Deutsche Forschungsgemeinschaft (He 551/8-2) and Boehringer Ingelheim. JP Sleeman was supported by a European Union Marie Curie Fellowship.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sleeman, J., Kim, U., LePendu, J. et al. Inhibition of MT-450 rat mammary tumour growth by antibodies recognising subtypes of blood group antigen B. Oncogene 18, 4485–4494 (1999). https://doi.org/10.1038/sj.onc.1202808
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202808